Greater admissions, mortality and cost of heart failure in adults with congenital heart disease.
Danielle S BursteinJoseph W RossanoHeather GriffisXuemei ZhangRachel FowlerBenjamin FrischertzYuli Y KimJoAnn LindenfieldJeremy A MazurekJonathan B EdelsonJonathan N MenachemPublished in: Heart (British Cardiac Society) (2020)
ACHD-HFs have significant ED and hospital resource use that has increased over the past 10 years. However, advanced HF therapies (VAD and transplantation) are less commonly used compared with those without adult congenital heart disease.